M-Pilar Marco Selected Research

M-Pilar Marco Research Topics

3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2014
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2020
2	Pseudomonas Infections 09/2020 - 02/2016
2	Infections 09/2020 - 11/2013
1	Stroke (Strokes) 01/2022
1	Pulmonary Embolism 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Myocardial Infarction 01/2022
1	Heart Failure 10/2020
1	Embolism (Embolus) 11/2018
1	Thrombosis (Thrombus) 11/2018
1	Atrial Fibrillation 11/2018
1	Body Weight (Weight, Body) 11/2018
1	Breast Neoplasms (Breast Cancer) 07/2018
1	Gynecomastia 07/2018
1	Metrorrhagia (Spotting) 07/2018
1	Immediate Hypersensitivity 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Neoplasms (Cancer) 06/2017
1	Staphylococcal Infections 08/2015

3	Biomarkers (Surrogate Marker)IBA 10/2020 - 02/2016
2	AcenocoumarolIBA 01/2022 - 11/2018
2	Kynurenic Acid (Kynurenate)IBA 01/2021 - 01/2020
2	Peptides (Polypeptides)IBA 10/2020 - 08/2015
2	AntibodiesIBA 07/2018 - 11/2013
1	Natriuretic PeptidesIBA 10/2020
1	Indicators and Reagents (Reagents)IBA 10/2020
1	pro-brain natriuretic peptide (1-76)IBA 10/2020
1	PhenazinesIBA 09/2020
1	AnticoagulantsIBA 11/2018
1	Anabolic Androgenic SteroidsIBA 07/2018
1	Pharmaceutical PreparationsIBA 07/2018
1	Hormones (Hormone)IBA 07/2018
1	Tamoxifen FDA LinkGeneric 07/2018
1	Disinfectants (Biocides)IBA 07/2018
1	TriazinesIBA 07/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 07/2018
1	Penicillins (Penicillin)FDA Link 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 06/2017
1	TegafurIBA 06/2017
1	ProdrugsIBA 06/2017
1	PyocyanineIBA 02/2016
1	1-hydroxyphenazineIBA 02/2016
1	Virulence Factors (Pathogenicity Factors)IBA 02/2016
1	EpitopesIBA 08/2015
1	Peptidoglycan (Murein)IBA 08/2015
1	Lipoprotein(a)IBA 09/2014
1	AntigensIBA 11/2013
1	Monoclonal AntibodiesIBA 11/2013

1	Drug Therapy (Chemotherapy) 06/2017